EMCDDA Home
  • EN
Search

Table PPP-9. Composition of illicit drug tablets, 2011

Part (iii) Sampling frame / type of monitoring system

CountryGeographical coverage / Timeframe / Sampling frame / Type of study
BelgiumNational / continuous / seized tablets sent to the laboratories for analysis / analysis develop by 11 laboratories including data from "Project drugs in circulation"
BulgariaNational / continuous / all seized tablets / routine analysis of seizures
Czech RepublicLocal (Prague) / continuous / random selection of seized tablets / routine analysis of seizures
DenmarkNational / continuous / all seized tablets sent to the three Forensic institutes/ routine analysis of seizures
GermanyNational / ongoing / all seized tablets/ routine analysis of seizures
EstoniaNational / continuous / all seized tablets / routine analysis of seizures
Ireland:
GreeceNational / continuous / all seized tablets / routine analysis of seizures
SpainNational / continuous - permanent / all seized tablets (mainly Madrid and Barcelona) / routine analysis of seizures
France-ANational / continuous / seized tablets by customs/ routine analysis of seizures
France-BNational / continuous / seized tablets by police forces/ routine analysis of seizures
ItalyNational - Region of Lazio / continuous / national seizures when number of tablets are greater than 50 and random sample of seizures over all Latium region by the State Police / routine analysis of seizures
CyprusNational / continuous / all seized tablets / routine analysis of seizures
LatviaNational / continuous - permanent / all seized tablets / routine analysis of seizures
Lithuania:
LuxembourgNational / continuous / random sample of tablets seized / routine analysis of seizures
HungaryNational / continuous / all seized tablets / routine analysis of seizures
MaltaNational / once per year / all seized tablets (only ecstasy like pills are reported to be tested for content) / routine analysis of seizures
NetherlandsNational / continuous / tablets sent to, about, 20 centres distributed over the country / routine analysis of samples collected at user level
AustriaLocal (Several dance events per year, mostly in Vienna) / Tablets sent to analysis from 7 dance events per year / routine analysis of samples collected at user level in the context of pill testing project
PolandNational / continuous / seized tablets sent to the Central Forensic Laboratory for analysis / analysis develop only for seizures with a minimum of 10 tablets of ecstasy
PortugalNational / continuous / all seized tablets (large and small) from traffic and traffic-use offences / routine analysis of seizures
Romania:
SloveniaNational / all seized tablets based on logos founded in the pills/ routine analysis of seizures
SlovakiaNational / permanent / all seized tablets / routine analysis of seizures
FinlandNational / all seized tablets / routine analysis of seizures. In cases of offences of use, the minor seizures will not all be submitted for analysis
SwedenNational / continuous and when requested / based on statistical measurements. When a seizure of tablets is macroscopically assessed to be equal approximately 10% is analysed / routine monitoring system
United KingdomEngland, Wales, Scotland / continuous / all seized tablets sent to FSS / England and Wales Police Forces who submit their drugs cases to The Forensic Science Service, Key Forensic Services, Environmental Service Group or LGC Forensics for analysis. Also includes Scottish data.
CroatiaNational / continuous - permanent / all seizures / routine analysis of seizures
TurkeyNational / continuous / all seized tablets / routine analysis of seizures
NorwayNational / continuous / all seized tablets sent for analysis / analysis develop normally for seizures exceeding 5 tablets
 

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Friday, 26 April 2013